Skip to main content
Erschienen in: Internal and Emergency Medicine 8/2022

30.07.2022 | IM - CASE RECORD

An unusual case of chronic diarrhea: a case report

verfasst von: Carola Maria Gagliardo, Davide Noto, Antonina Giammanco, Annalisa Savoja, Marcella Panzica, Giuseppe Lavatura, Rosalia Lo Presti, Angelo Baldassare Cefalù, Maurizio Averna

Erschienen in: Internal and Emergency Medicine | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Excerpt

Gastroenteropancreatic-neuroendocrine neoplasms or tumors (GEP-NEN or NETs) are rare tumors arising from the diffuse neuroendocrine system. Their annual incidence is less than 5 cases per 100,000 inhabitants [1]. NETs are classified as non-functional or functional tumors. The latter have a better prognosis and are associated with hormonal syndromes. NETs’ clinical presentation can be characterized by non-specific symptoms, such as diarrhea, weight loss, hypoglycemia, rectal bleeding, and also by flushing and wheezing/asthma-like symptoms when Carcinoid Syndrome is the underlying cause of symptoms. Manifestations of non-functional tumors are mainly related to compression of neighboring anatomical structures [2, 3]. Because of their non-specific symptoms, NETs are often misdiagnosed. This case report describes a nuanced and very insidious clinical presentation of Atypical Carcinoid Syndrome due to a GEP-NEN, characterized by chronic diarrhea as primary symptom. Although several cases of diarrhea due to GEP-NENs are reported in the literature [4], this case underlines how a simple clinical symptom may hide a complex diagnosis. This clinical case highlights the complexity of the diagnostic process and the difficulties in interpreting the examinations for this type of tumor, showing how the negativity of first-level examinations did not prevent from performing further investigations, in the presence of a suggestive clinical presentation. The search of similar cases in the published literature suggests that this represents an unusual presentation of a NET. …
Literatur
2.
Zurück zum Zitat ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103(2):153–71.CrossRefPubMed ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016;103(2):153–71.CrossRefPubMed
3.
Zurück zum Zitat Ito T, Lee L, Jensen RT (2018) Carcinoid-syndrome: recent advances, current status and controversies. Curr Opin Endocrinol Diabetes Obes 25(1):22–35CrossRefPubMedPubMedCentral Ito T, Lee L, Jensen RT (2018) Carcinoid-syndrome: recent advances, current status and controversies. Curr Opin Endocrinol Diabetes Obes 25(1):22–35CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Khan MS, Walter T, Buchanan-Hughes A, Worthington E, Keeber L, Feuilly M et al. Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: a systematic review. World J Gastroenterol. 2020 Aug 14;26(30):4537–4556.CrossRefPubMedPubMedCentral Khan MS, Walter T, Buchanan-Hughes A, Worthington E, Keeber L, Feuilly M et al. Differential diagnosis of diarrhoea in patients with neuroendocrine tumours: a systematic review. World J Gastroenterol. 2020 Aug 14;26(30):4537–4556.CrossRefPubMedPubMedCentral
5.
7.
Zurück zum Zitat Albishi AM, Mostafa AMM, Ali HM, Alhagawi YA, Bazeed MF, Hussein MRA, Aloba EEMA, Aboelyazid AY. Incidence of Gastrointestinal Neuroendocrine Tumor: Case Series, Armed Forces Hospital Southern Region, Hospital-Based Tumor Board Registry. Case Rep Oncol Med. 2020 Oct 20;2020:8819392. Albishi AM, Mostafa AMM, Ali HM, Alhagawi YA, Bazeed MF, Hussein MRA, Aloba EEMA, Aboelyazid AY. Incidence of Gastrointestinal Neuroendocrine Tumor: Case Series, Armed Forces Hospital Southern Region, Hospital-Based Tumor Board Registry. Case Rep Oncol Med. 2020 Oct 20;2020:8819392.
8.
Zurück zum Zitat Naraev BJ, Halland M, Halperin DM, Purvis AJ, OʼDorisio TM, Halfdanarson TR, (2019) Management of diarrhea in patients with carcinoid syndrome. Pancreas 48(8):961–972CrossRefPubMedPubMedCentral Naraev BJ, Halland M, Halperin DM, Purvis AJ, OʼDorisio TM, Halfdanarson TR, (2019) Management of diarrhea in patients with carcinoid syndrome. Pancreas 48(8):961–972CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Kapoor R, Bhattacharyya T, Gupta R, Mittal B, Kalra N (2014) A systematic review of management of neuroendocrine tumors: an experience from a tertiary care centre from India. Clin Cancer Investig J 3(5):363–372CrossRef Kapoor R, Bhattacharyya T, Gupta R, Mittal B, Kalra N (2014) A systematic review of management of neuroendocrine tumors: an experience from a tertiary care centre from India. Clin Cancer Investig J 3(5):363–372CrossRef
11.
Zurück zum Zitat Thompson AA, Suhail FK, Mirchia K, Rawlins SR. A Case of Profound Secretory Diarrhea Revealing 2 Primary Neuroendocrine Tumors. ACG Case Rep J. 2021 Jul 8;8(7):e00625.CrossRefPubMedPubMedCentral Thompson AA, Suhail FK, Mirchia K, Rawlins SR. A Case of Profound Secretory Diarrhea Revealing 2 Primary Neuroendocrine Tumors. ACG Case Rep J. 2021 Jul 8;8(7):e00625.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Tirosh A, Kebebew E (2018) The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol 14(2):111–122CrossRefPubMed Tirosh A, Kebebew E (2018) The utility of 68Ga-DOTATATE positron-emission tomography/computed tomography in the diagnosis, management, follow-up and prognosis of neuroendocrine tumors. Future Oncol 14(2):111–122CrossRefPubMed
13.
Zurück zum Zitat Dam G, Grønbæk H, Sorbye H, Evensen E, Paulsson B, Sundin A et al (2020) Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small-intestinal, and unknown primary neuroendocrine tumors. Neuroendocrinology 110(3–4):217–224CrossRefPubMed Dam G, Grønbæk H, Sorbye H, Evensen E, Paulsson B, Sundin A et al (2020) Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small-intestinal, and unknown primary neuroendocrine tumors. Neuroendocrinology 110(3–4):217–224CrossRefPubMed
14.
Zurück zum Zitat Wedin M, Mehta S, Angerås-Kraftling J, Wallin G, Daskalakis K (2021) The role of serum 5-HIAA as a predictor of progression and an alternative to 24-h urine 5-HIAA in well-differentiated neuroendocrine neoplasms. Biology (Basel) 10(2):76 Wedin M, Mehta S, Angerås-Kraftling J, Wallin G, Daskalakis K (2021) The role of serum 5-HIAA as a predictor of progression and an alternative to 24-h urine 5-HIAA in well-differentiated neuroendocrine neoplasms. Biology (Basel) 10(2):76
15.
Zurück zum Zitat Cai B, Broder MS, Chang E, Yan T, Metz DC (2017) Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors. World J Gastroenterol 23:7283–7291CrossRefPubMedPubMedCentral Cai B, Broder MS, Chang E, Yan T, Metz DC (2017) Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors. World J Gastroenterol 23:7283–7291CrossRefPubMedPubMedCentral
Metadaten
Titel
An unusual case of chronic diarrhea: a case report
verfasst von
Carola Maria Gagliardo
Davide Noto
Antonina Giammanco
Annalisa Savoja
Marcella Panzica
Giuseppe Lavatura
Rosalia Lo Presti
Angelo Baldassare Cefalù
Maurizio Averna
Publikationsdatum
30.07.2022
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 8/2022
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03055-0

Weitere Artikel der Ausgabe 8/2022

Internal and Emergency Medicine 8/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.